US Patent 7524980 Vitamin D
Patent 7524980 was granted and assigned to Teijin Pharma on April, 2009 by the United States Patent and Trademark Office.
All edits
Edits on 15 Sep, 2023
Golden AI
Edits made to:
Article (+199 characters)
Article
Patent abstract
Compounds expressed by the following formula (1) or pharmaceutically permissible solvate thereof which is effective for treating Paget's disease of bone, hypercalcemia or osteoporosis.
Edits on 23 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 07524980 Vitamin D US Patent 7524980 Vitamin D
Infobox
Patent Number
0752498000
Patent Number
752498000
Edits on 19 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 22 Apr, 2023
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
075249800
Date of Patent
April 28, 2009
0Patent Application Number
109802530
Date Filed
November 4, 2004
0Official Website
Patent Primary Examiner
Edits on 27 Sep, 2022
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
075249800
Date of Patent
April 28, 2009
0Patent Application Number
109802530
Date Filed
November 4, 2004
0Official Website
Patent Primary Examiner
Edits on 15 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 2 Dec, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 07524980 Vitamin D
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
07524980
Date of patent
April 28, 2009
Patent application number
10980253
Date Filed
November 4, 2004
Patent primary examiner
Find more entities like US Patent 7524980 Vitamin D
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.